hide You are viewing an archived web page, collected at the request of U.S. Department of Health and Human Services using Archive-It. This page was captured on 14:43:12 Oct 17, 2018, and is part of the Advisory Committees collection. The information on this web page may be out of date. See All versions of this archived page. Found 0 archived media items out of 0 total on this page.

This is archived HHS content.

Webcast of February 4, 2009 Vaccine Safety Working Group Meeting

The of the National Vaccine Advisory Committee, NVAC) has sought broad public input into the scientific research agenda that is being developed by the Centers for Disease Control and Prevention's (CDC) Immunization Safety Office (ISO).

At its , the NVAC Vaccine Safety Working Group discussed outcomes and issues highlighted in three public engagement sessions held earlier in Birmingham, Alabama; Ashland, Oregon; and Indianapolis, Indiana. A summary of the written comments sent to HHS on the CDC ISO research agenda was also discussed.

View the archived Webcast - 270 minutes.
[RealPlayer is required to view the Webcast.]

Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group

Overview: Why did you attend a community meeting about vaccine saftey?

Duration: 1:24 minutes
You will need Flash (https://www.adobe.com) installed on your computer in order to view the video.<

	Tracy Cron, Birmingham, AL - 1:47 minutes
	Toni DiLeo, Ashland, OR - 2:23 minutes
	Bernard Richard, Indianapolis, IN - 2:12 minutes
	Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group - 1:24 minutes